Adding evorpacept to treatment with trastuzumab, ramucirumab, and paclitaxel may improve outcomes in HER2-positive gastric/GEJ cancer.

Apologies can help improve the quality of the treatment relationship by restoring trust and sharing power with the patient.

Perioperative chemotherapy improved outcomes when compared to preoperative chemoradiotherapy in a phase 3 trial of patients with resectable esophageal cancer. Results from this tr ...